Northwestern Mutual Wealth Management Co. purchased a new position in shares of Cigna Group (NYSE:CI - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 22,311 shares of the health services provider's stock, valued at approximately $6,151,000.

• UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider's stock worth $7,203,754,000 after purchasing an additional 414,834 shares during the last quarter. BlackRock Inc. increased its stake in Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock valued at $6,461,457,000 after buying an additional 840,098 shares during the last quarter. State Street Corp increased its stake in Cigna Group by 1.8% in the 4th quarter. State Street Corp now owns 12,339,250 shares of the health services provider's stock valued at $3,396,132,000 after buying an additional 224,122 shares during the last quarter. Dodge & Cox lifted its position in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider's stock worth $3,065,681,000 after buying an additional 1,833,389 shares in the last quarter. Finally, GQG Partners LLC boosted its stake in shares of Cigna Group by 14.3% during the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider's stock worth $2,136,699,000 after buying an additional 972,302 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of the firm's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares of the company's stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company's stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is owned by company insiders.

Analyst Ratings Changes

• The AI Boom Has a Second Act—And It's Playing Out in Optics

A number of analysts recently issued reports on the company. UBS Group lifted their target price on Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, May 22nd. Raymond James Financial cut Cigna Group from a "strong-buy" rating to an "outperform" rating and reduced their price target for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Royal Bank Of Canada raised their price target on Cigna Group from $333.00 to $337.00 and gave the company an "outperform" rating in a research note on Friday, May 1st. Mizuho boosted their price target on Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Finally, Piper Sandler dropped their price objective on Cigna Group from $370.00 to $346.00 and set an "overweight" rating on the stock in a research note on Wednesday, June 3rd. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Cigna Group presently has an average rating of "Moderate Buy" and an average price target of $339.45.

Check Out Our Latest Research Report on Cigna Group

Cigna Group Trading Down 0.5%

• Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum

Cigna Group stock opened at $276.19 on Monday. The stock has a 50-day simple moving average of $284.20 and a 200 day simple moving average of $281.45. The stock has a market capitalization of $72.98 billion, a P/E ratio of 11.43, a PEG ratio of 0.95 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the company earned $7.20 earnings per share. The business's revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group's dividend payout ratio is 25.82%.

Cigna Group Company Profile

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

• Five stocks we like better than Cigna Group
• VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
• 3 Closed-End Funds to Maximize Dividend Payments
• Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
• $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here